139 related articles for article (PubMed ID: 7338883)
1. Defective activation of the alternative pathway of complement in two brothers with ataxia-telangiectasia.
Saint-Remy JM; Dent RG; Cole P
J Clin Lab Immunol; 1981 Nov; 6(3):221-6. PubMed ID: 7338883
[TBL] [Abstract][Full Text] [Related]
2. Leucocyte migration inhibition factor (LIF) production by lymphocytes of normal children, newborns, and children with immune deficiency.
Hahn T; Levin S; Handzel ZT
Clin Exp Immunol; 1976 Jun; 24(3):448-54. PubMed ID: 133010
[TBL] [Abstract][Full Text] [Related]
3. Selective defects in T cell function in ataxia-telangiectasia.
Levis WR; Dattner AM; Shaw JS
Clin Exp Immunol; 1979 Jul; 37(1):44-9. PubMed ID: 158450
[TBL] [Abstract][Full Text] [Related]
4. Twenty-year follow-up of 160 patients with ataxia-telangiectasia.
Ersoy F; Berkel AI; Sanal O; Oktay H
Turk J Pediatr; 1991; 33(4):205-15. PubMed ID: 1814037
[TBL] [Abstract][Full Text] [Related]
5. [Immunologic and cytogenetic aspects of ataxia telangiectasia].
Weemaes CM; Taalman RD; Van Munster PJ; Hustinx TW; Bakkeren JA; Scheres JM
Tijdschr Kindergeneeskd; 1984 Aug; 52(4):164-9. PubMed ID: 6333737
[TBL] [Abstract][Full Text] [Related]
6. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of the immunological deficiency in ataxia-telangiectasia: absence of a clinical-pathological correlation.
Roifman CM; Gelfand EW
Kroc Found Ser; 1985; 19():273-85. PubMed ID: 3877786
[TBL] [Abstract][Full Text] [Related]
8. Immunodeficiency and infections in ataxia-telangiectasia.
Nowak-Wegrzyn A; Crawford TO; Winkelstein JA; Carson KA; Lederman HM
J Pediatr; 2004 Apr; 144(4):505-11. PubMed ID: 15069401
[TBL] [Abstract][Full Text] [Related]
9. Defective anti-polysaccharide antibody response in patients with ataxia-telangiectasia.
Sanal O; Ozbaş-Gerçeker F; Yel L; Ersoy F; Tezcan I; Berkel AI; Metin A; Gatti RA
Turk J Pediatr; 2004; 46(3):208-13. PubMed ID: 15503472
[TBL] [Abstract][Full Text] [Related]
10. Abnormal OKT4/OKT8 ratio and deranged capping in ataxia-telangiectasia.
Barbieri MC; Bertanza C; Ferrero E; Colombo G; Baldini V; Besana C
Boll Ist Sieroter Milan; 1985; 64(3):232-5. PubMed ID: 3840025
[TBL] [Abstract][Full Text] [Related]
11. Ataxia-telangiectasia patients presenting with hyper-IgM syndrome.
Noordzij JG; Wulffraat NM; Haraldsson A; Meyts I; van't Veer LJ; Hogervorst FB; Warris A; Weemaes CM
Arch Dis Child; 2009 Jun; 94(6):448-9. PubMed ID: 19224889
[TBL] [Abstract][Full Text] [Related]
12. Ataxia-telangiectasia: a clinical and laboratory review study of 14 cases.
Schwartzman JS; Solé D; Naspitz CK
Allergol Immunopathol (Madr); 1990; 18(2):105-11. PubMed ID: 1695474
[TBL] [Abstract][Full Text] [Related]
13. Ataxia telangiectasia with hepatocellular carcinoma in a 15-year-old girl and studies of her kindred.
Weinstein S; Scottolini AG; Loo SY; Caldwell PC; Bhagavan NV
Arch Pathol Lab Med; 1985 Nov; 109(11):1000-4. PubMed ID: 2996458
[TBL] [Abstract][Full Text] [Related]
14. [Ataxia telangiectasia: 3 clinical cases with immunological study and autopsy report].
Grossi-Bianchi ML; Moscatelli P; Tassara A
Minerva Pediatr; 1971 Aug; 23(33):1350-8. PubMed ID: 5122472
[No Abstract] [Full Text] [Related]
15. The immunological deficiency state in ataxia-telangiectasia.
McFarlin DE; Strober W; Barlow M; Waldmann T
Res Publ Assoc Res Nerv Ment Dis; 1971; 49():275-92. PubMed ID: 4943905
[No Abstract] [Full Text] [Related]
16. [Cell mediated cytotoxic activities in ataxia-telangiectasia with T cell deficiency].
Tsuge I; Matsuoka H; Okada J; Mizuno T; Matsuoka M; Torii S; Kodera Y; Takahashi T
Arerugi; 1984 Oct; 33(10):909-16. PubMed ID: 6335392
[No Abstract] [Full Text] [Related]
17. Ataxia-telangiectasia. X,14 translocation, progressive deterioration of lymphocyte numbers and function, and abnormal in vitro immunoglobulin production.
Beatty DW; Arens LJ; Nelson MM
S Afr Med J; 1986 Jan; 69(2):115-8. PubMed ID: 2417340
[TBL] [Abstract][Full Text] [Related]
18. [Lymphoblastic transformation, chromosome picture and delayed skin reaction in ataxia teleangiectasia].
Schuler D; Schöngut L; Cserháti E; Siegler J; Gács G
Orv Hetil; 1969 Sep; 110(39):2279-82. PubMed ID: 4187094
[No Abstract] [Full Text] [Related]
19. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
Lagergård T; Frisk A; Purvèn M; Nilsson LA
Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
[TBL] [Abstract][Full Text] [Related]
20. Transfer factor therapy in ataxia--telangiectasia.
Berkel AI; Ersoy F; Epstein LB; Spitler LE
Clin Exp Immunol; 1977 Sep; 29(3):376-84. PubMed ID: 201409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
